selected publications

• article

  • A longitudinal multiethnic study of biomarkers in systemic lupus erythematosus: Launching the GLADEL 2.0 Study Group.  Lupus.  :-. 2021-01-01
    
  • Mortality and adverse events of special interest with intravenous belimumab for adults with active, autoantibody-positive systemic lupus erythematosus (BASE): a multicentre, double-blind, randomised, placebo-controlled, phase 4 trial.  The Lancet Rheumatology.  3:e122-e130. 2021-01-01